Similarly, the TGF-β pathway converts from a tumoural inhibiting to a pro-metastatic role in advanced HCC, which triggers immunosuppresion and ECM degradation by matrix metalloproteinases (MMPs) [31]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.